Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance

Blood (2018) 132 (6): 666–670.

https://doi.org/10.1182/blood-2018-02-833608

Published: 2018

Journal Articles

Evaluation Of Immunoglobulin Variations (Clonal Changes) In Symptomatic Multiple Myeloma (MM) Patients’ Course

Eftychia Nikolaou, Panayiotis Panayiotidis, MD, Katerina Sarris, Dimitrios Maltezas, MD, Efstathios Koulieris, Theodoros Iliakis, Nora Vyniou, Ioanna Vardounioti, Vassiliki Karali, Ilias Pessach, Anna Efthymiou, MD, Vassiliki Bartzis, Tatiana Tzenou, MD, Maria Dimou, Theodoros P. Vassilakopoulos, Maria K. Angelopoulou, Panagiotis Tsaftaridis, Nikolitsa Kafasi, Marie-Christine Kyrtsonis, MD

Blood (2013) 122 (21): 3173.

https://doi.org/10.1182/blood.V122.21.3173.3173

Published: 2013

Journal Articles

The Presence Of Spine Bone Plasmacytomas At The Time Of Multiple Myeloma (MM) Diagnosis Confers Poor Prognosis

Marie-Christine Kyrtsonis, MD, Eftychia Nikolaou, Dimitrios Maltezas, MD, Katerina Sarris, Efstathios Koulieris, Theodoros Iliakis, Nora Vyniou, Ioanna Vardounioti, Vassiliki Karali, Ilias Pessach, Vassiliki Bartzis, Tatiana Tzenou, MD, Maria Dimou, Theodoros P. Vassilakopoulos, Maria K. Angelopoulou, Panagiotis Tsaftaridis, Irene Katodritou, Panayiotis Panayiotidis, MD

Blood (2013) 122 (21): 5366.

https://doi.org/10.1182/blood.V122.21.5366.5366

Published: 2013

Journal Articles

Impact of Novel M-Component Based Biomarkers On to Progression Free Survival After Treatment in Intact Immunoglobulin Multiple Myeloma.

Efstathios Koulieris, Dimitrios Maltezas, Nikolaou Eytychia, Vassiliki Bartzis, Tatianna Tzenou, Vassiliki Karali, Pessach Ilias, Katerina Sarris, Stephen Harding, Arthur Bradwell, FRCP, FRCPath, Theodoros P. Vassilakopoulos, Maria K. Angelopoulou, Nikolitsa Kafasi, Panayiotis Panayiotidis, Marie-Christine Kyrtsonis

Blood (2012) 120 (21): 2927.

https://doi.org/10.1182/blood.V120.21.2927.2927

Published: 2012

Journal Articles

A Shorter Time to First Treatment and Worst Overall survival Is Observed in Cll Patients with Reduced Serum IgM As Evaluated with Novel Serum Immunoassays

Blood (2012) 120 (21): 4585.

https://doi.org/10.1182/blood.V120.21.4585.4585

Published: 2012

Journal Articles

Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia (cll) Prognosis

Blood (2012) 120 (21): 4568.

https://doi.org/10.1182/blood.V120.21.4568.4568

Published: 2012

Journal Articles

Increased Serum Transforming Growth Factor-beta1 (Tgf-beta1) Is Related to a Better Outcome in MM, WM and CLL Patients

Dimitrios Maltezas, Katerina Sarris, Efstathios Koulieris, Tatiana Tzenou, Vassiliki Bartzis, Eftychia Nikolaou, Maria Gavriatopoulou, Maria Dimou, Evangelos Terpos, Maria K. Angelopoulou, Theodoros P. Vassilakopoulos, Panayiotis Panayiotidis, Gerasimos Pangalis, Meletios A Dimopoulos, MD, Marie-Christine Kyrtsonis

Blood (2012) 120 (21): 4976.

https://doi.org/10.1182/blood.V120.21.4976.4976

Published: 2012

Journal Articles

Heavy Chain Ratio (HLCR) IgGκ/IgGλ or IgAκ/IgAλ: Experience and Clinical Implications In Multiple Myeloma at Diagnosis and During Disease Course

Efstathios Koulieris, Marie-Christine Kyrtsonis, Nikolitsa Kafassi, Dimitris Maltezas, Vassiliki Bartzis, Tatiana Tzenou, Maria Dimou, George Georgiou, Ladan Mirbahai, Panayiotis Panayiotidis, Arthur Bradwell, FRCP, FRCPath, Stephen Harding, PhD

Blood (2010) 116 (21): 5019.

https://doi.org/10.1182/blood.V116.21.5019.5019

Published: 2010

Journal Articles

No Significant Improvement In the Outcome of Patients with Waldenström's Macroglobulinemia Treated Over the Last 25 Years

Blood (2010) 116 (21): 3032.

https://doi.org/10.1182/blood.V116.21.3032.3032

Published: 2010

Journal Articles

The International Scoring System (ISS) for Multiple Myeloma Remains a Robust Prognostic Tool Independently of Patients' Renal Function

Blood (2010) 116 (21): 3036.

https://doi.org/10.1182/blood.V116.21.3036.3036

Published: 2010

Journal Articles

Quantification of Serum IgMκ and IgMλ In Patients with Waldenstrom's Macroglobulinemia (WM) at Diagnosis and During Disease Course; Clinical Correlations

Efstathios Koulieris, Marie-Christine Kyrtsonis, Dimitris Maltezas, Tatiana Tzenou, Ladan Mirbahai, Nikolitsa Kafassi, Vassiliki Bartzis, Maria Dimou, George Georgiou, Charis Matsouka, Gerasimos Pangalis, Panayiotis Panayiotidis, Arthur Bradwell, FRCP, FRCPath, Stephen Harding, PhD

Blood (2010) 116 (21): 3004.

https://doi.org/10.1182/blood.V116.21.3004.3004

Published: 2010

Journal Articles

Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's Macroglobulinemia (WM) and the Importance of Serum Lactate Dehydrogenase (LDH).

Blood (2009) 114 (22): 2845.

https://doi.org/10.1182/blood.V114.22.2845.2845

Published: 2009

Journal Articles

Serum Free Light Chain and Serum Heavy / Light Chain Ratios Are Independently Prognostic in Multiple Myeloma Patients.

Efstathios Koulieris, Stephen Harding, PhD, Marie-Christine Kyrtsonis, Caroline Bradley, Mark T Drayson, Gareth J Morgan, J. Anthony Child, Arthur Bradwell, FRCP, FRCPath

Blood (2009) 114 (22): 4880.

https://doi.org/10.1182/blood.V114.22.4880.4880

Published: 2009

Journal Articles

Increased Immunohistochemical CD138 Expression in Waldenström's Macroglobulinemia (WM) in Comparison with Splenic Marginal Zone Lymphoma (SMZL).

Tatiana K Tzenou, G.A. Pangalis, Georgia Levidou, Christina Kalpadakis, Spyros Siakavellas, Dimitrios Maltezas, Efstathios Koulieris, Maria Dimou, Vasiliki Bartzi, Georgios Georgiou, Theodoros P. Vassilakopoulos, Maria K. Angelopoulou, Styliani Kokkoris, Penelope Korkolopoulou, Athina Androulaki, Eystathios Patsouris, Panayiotis Panayiotidis, Marie-Christine Kyrtsonis

Blood (2009) 114 (22): 5008.

https://doi.org/10.1182/blood.V114.22.5008.5008

Published: 2009

NARROW

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance

Evaluation Of Immunoglobulin Variations (Clonal Changes) In Symptomatic Multiple Myeloma (MM) Patients’ Course

The Presence Of Spine Bone Plasmacytomas At The Time Of Multiple Myeloma (MM) Diagnosis Confers Poor Prognosis

Impact of Novel M-Component Based Biomarkers On to Progression Free Survival After Treatment in Intact Immunoglobulin Multiple Myeloma.

A Shorter Time to First Treatment and Worst Overall survival Is Observed in Cll Patients with Reduced Serum IgM As Evaluated with Novel Serum Immunoassays

Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia (cll) Prognosis

Increased Serum Transforming Growth Factor-beta1 (Tgf-beta1) Is Related to a Better Outcome in MM, WM and CLL Patients

Heavy Chain Ratio (HLCR) IgGκ/IgGλ or IgAκ/IgAλ: Experience and Clinical Implications In Multiple Myeloma at Diagnosis and During Disease Course

No Significant Improvement In the Outcome of Patients with Waldenström's Macroglobulinemia Treated Over the Last 25 Years

The International Scoring System (ISS) for Multiple Myeloma Remains a Robust Prognostic Tool Independently of Patients' Renal Function

Quantification of Serum IgMκ and IgMλ In Patients with Waldenstrom's Macroglobulinemia (WM) at Diagnosis and During Disease Course; Clinical Correlations

Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's Macroglobulinemia (WM) and the Importance of Serum Lactate Dehydrogenase (LDH).

Serum Free Light Chain and Serum Heavy / Light Chain Ratios Are Independently Prognostic in Multiple Myeloma Patients.

Increased Immunohistochemical CD138 Expression in Waldenström's Macroglobulinemia (WM) in Comparison with Splenic Marginal Zone Lymphoma (SMZL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only